BSE filing, NSE: SANOFICONR. Summary written from the filing by ALFA Finder's alert engine.
Sanofi Consumer Healthcare India Ltd: key numbers
- Share price
- ₹3,566.40
- Market cap
- ₹8,214 Cr
- Revenue (annual)
- ₹878.4 Cr
- Net profit (annual)
- ₹240.1 Cr
- P/E (TTM)
- 29.4×Sector 43.8×
- Promoter holding
- 71.27%+0.00% QoQ
- FII holding
- 2.48%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sanofi Consumer Healthcare India Ltd
All →Sanofi Consumer Healthcare India Annual General Meeting
Sanofi Consumer Healthcare sought shareholder approval via postal ballot for material related party transactions with Opella entities. E-voting closes 6 December 2026.
Sanofi Consumer Healthcare India Q2 FY27 Results: Net Profit ₹76.6 Cr, Up 21.8% YoY
Sanofi Consumer Healthcare India Ltd reported revenue from operations of ₹263.1 Cr (+12.5% YoY) and net profit of ₹76.6 Cr (+21.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹76.6 Cr · +21.8% YoY
Sanofi Consumer Healthcare India Board Meeting Date
Sanofi Consumer Healthcare India Limited will hold a board meeting on 28 October 2026 to consider its standalone unaudited financial results for the September 2026 quarter.
Sanofi Consumer Healthcare India Other Announcement
Sanofi Consumer Healthcare India Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. The disclosure provides details of shareholding across various investor categories.
Sanofi Consumer Healthcare India Q1 FY27 Results: Net Profit ₹68.8 Cr, Up 13.3% YoY
Sanofi Consumer Healthcare India Ltd reported revenue from operations of ₹235.7 Cr (+6.7% YoY) and net profit of ₹68.8 Cr (+13.3% YoY) for Q1 FY27.
- Key figure
- Net profit ₹68.8 Cr · +13.3% YoY
Sanofi Consumer Healthcare India Board Meeting Date
Sanofi Consumer Healthcare India Limited will hold a board meeting on 28th July 2026 to consider and approve its unaudited financial results.
Other annual report announcements
All →Mrugesh Trading Annual Report
Mrugesh Trading submitted its FY2025-26 Annual Report for the 42nd AGM to be held on 30 September 2026. The filing contains the full annual report, including financials and governance disclosures.
Generic Engineering Construction and Projects Annual Report
Generic Engineering filed its FY2025-26 Annual Report ahead of its 32nd AGM on 30 November 2026. The filing covers board changes and a planned bank-funded EPC expansion.
Vineet Laboratories Annual Report
Vineet Laboratories filed its FY 2025-26 Annual Report, which marks its turnaround and recapitalisation year. The AGM is scheduled for 30 November 2026.
Indrayani Biotech Annual Report
Indrayani Biotech has filed its 34th Annual Report for FY2025-26, containing the AGM notice for 30 November 2026 by VC/OAVM. The chairman notes a Rights Issue was initiated in October 2026 to raise capital.
ESDS Software Solution Annual Report
ESDS Software Solution submitted its FY2025-26 Annual Report along with the AGM notice. The AGM is on 30 November 2026 via VC/OAVM, with remote e-voting.
The Orissa Minerals Development Company Annual Report
Orissa Minerals Development Company filed its FY 2025-26 Annual Report and 108th AGM notice, with the AGM set for 30 November 2026. The filing is a Regulation 34 intimation with no transaction or financial event.